you have already worked on this for me however all i need is for you to ad my information in the appropriate section of the powerpoint. I have attached the outline as a reference to ensure you know where on the powerpoint it goes. My section is section V.
Michelle_Michy
20200708033856group_project_chadox1_candidate_vaccine_for_covid_191.pptxChAdOx1 Candidate Vaccine for CoVid-19
Ju Brown, Carley Czyzewski,
Maria Kayes, Alondra Olan Baez & Nneka Onianwah
Professor Schwartz
University of Maryland Global Campus
Biology 302
Introduction of the title and presenters.
1
What is a virus?
A virus is microscopic organism that rely on a host to make more of itself.
A virus is made of nuclei acid, capsid, viral envelope.
Figure 1. Structure of Virus from UMGC, Module 4.
Nucleic acid is the genetic material of the virus and can be made of DNA or RNA. The capsid (protein coat) is what protects the virus genetic materials and gives it its shape. The envelope is the outer layer of the virus and it displays spikes that play an important role in attachment to the host cell (UMGC, Module 4).
2
Why does a virus make people sick?
The virus causes people to get sick for two reasons:
while it is reproducing it can damage organs.
the immune system tries to fight the virus causing inflammation and fever (Johns Hopkins University of Medicine, n. d.).
The virus causes disease and illness because while it is reproducing it can damage organs, altering the normal bodily functions. As a result, the immune system tries to fight the virus causing inflammation and fever (Johns Hopkins University of Medicine, n. d.).
3
Characteristics of SArS-CoV-2
COVID-19, also known as SArS-CoV-2
SArS-CoV-2 infects humans by hijacking the cells in order to replicate itself.
Transmission rate is high because the human body does not have immunity (Johns Hopkins University of Medicine, n. d.).
COVID-19, also known as SArS-CoV-2, (severe acute respiratory syndrome coronavirus 2) is a RNA virus that causes mild to severe respiratory illness.
SArS-CoV-2 infects humans by entering the host and hijacking the cells in order to replicate itself.
Transmission rate is high because SArS-CoV-2 is a new viral infection and the human body does not have immunity to it (Johns Hopkins University of Medicine, n. d.).
4
References
UMGC (n.d.) Course Module 4: Viruses in BIOL 302. Document posted in University of Maryland Global Campus (UMGC) BIOL 302 6981 (2205) online classroom retrieved from https://learn.umgc.edu/d2l/le/content/535017/viewContent/18683959/View
UMGC (n.d.) Course Module 4: Viruses in BIOL 302. Figure 4.2 Components of a Typical VirionDocument posted in University of Maryland Global Campus (UMGC) BIOL 302 6981 (2205) online classroom retrieved from https:// learn.umgc.edu/d2l/le/content/535017/viewContent/18683959/View
Johns Hopkins University of Medicine (n.d.) Modules 1 and 3 in Understanding the COVID-19 Pandemic: Insights from Johns Hopkins University Experts. https://coronavirus.jhu.edu
References
NIH (2020, May 15) Investigational ChAdOx1 nCoV-19 vaccine protects monkeys against COVID-19 pneumonia. National Institutes of Health (NIH). https://www.nih.gov/news-events/news-releases/investigational-chadox1-ncov-19-vaccine-protects-monkeys-against-covid-19-pneumonia
Institute of Medicine (1993, January 01) Committee on the Children's Vaccine Initiative: Planning Alternative Strategies. Stages of Vaccine Development. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK236428 /
University of Oxford (2020, May 22) Oxford COVID-19 vaccine to begin phase II/III human trials. News http://www.ox.ac.uk/news/2020-05-22-oxford-covid-19-vaccine-begin-phase-iiiii-human-trials
